Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
What is in question, though, is how to support those taking these medications so that they can look and feel their best and maintain their health throughout their medical weight loss journey
Raun K et al
Supplements This brings us to the most important part of the conversation
Not just chemistry, but biology, precision design, and regulatory depth are now becoming essential to compete in this space." Hari Kiran Chereddi, MD & CEO, HRV Pharma and NHG Pharma GLP-1 Patent Expiry Timeline and Market Dynamics The market opportunity is defined by several critical factors: Patent Expiration: Semaglutide's key patents expire globally by early 2026 Market Growth: Demand for obesity and diabetes treatments growing 12-14% year-over-year Healthcare Savings: Indian companies can save global healthcare systems billions through cost-effective alternatives Regulatory Access: Opportunities to develop biosimilars or complex generics for US and EU markets Beyond Cost Competition: Value-Based Differentiation The competitive landscape for GLP-1 drugs extends beyond traditional cost advantages that have historically defined Indian pharmaceutical success
The GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype
